Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials

Explore recruiting chronic inflammatory demyelinating polyradiculoneuropathy clinical trials.

Recruiting chronic inflammatory demyelinating polyradiculoneuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, multicenter, open-label, non-randomized, proof-of-concept study evaluating the efficacy, safety, and tolerability of SAR445088 in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)

Poland, Germany, France, Spain, Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Denmark, Czechia, Sweden, Poland, Italy, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Croatia, Belgium, France, Italy, Germany, Spain +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Xembify versus Gamunex-C in Participants with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Romania, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Spain, France, Poland, Bulgaria, Belgium, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Italy, Greece, Czechia, Poland, Germany, France +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials by city

Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Toronto Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Vancouver Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Montreal Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Calgary Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Edmonton Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Ottawa Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Winnipeg Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Quebec City Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Hamilton Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Kitchener Chronic Inflammatory Demyelinating Polyradiculoneuropathy in London Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Halifax Chronic Inflammatory Demyelinating Polyradiculoneuropathy in New York Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Los Angeles Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Chicago Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease